Nyxoah Partners with American Association of Otolaryngology to Expand Patient Access

Nyxoah S.A. NYXH, a healthtech company focused on the development and commercialization of solutions and services to treat respiratory disorders during sleep, has taken a significant step forward in advancing its patient access strategy. The company has announced a partnership with the American Association of Otolaryngology - Head & Neck Surgery Foundation (AAO-HNSF), becoming the first medical device company to attain the status of corporate champion at the ENTerprise Circle level. This strategic collaboration aims to enhance patient access to Nyxoah's innovative therapies, potentially improving outcomes for those suffering from sleep-disordered breathing conditions.

Strategic Partnership Advantages

The collaboration between Nyxoah and AAO-HNSF presents numerous benefits. By joining forces with a leading professional organization, Nyxoah is poised to leverage the AAO-HNSF's extensive network and resources. This partnership underscores the commitment to provide more patients with access to novel medical solutions, profoundly impacting the field of otolaryngology and the broader medical community.

Fostering Innovation and Access

Nyxoah's role as a corporate champion at the ENTerprise Circle level within the AAO-HNSF reflects a shared vision of fostering innovation and broadening patient access to state-of-the-art medical devices. The collaboration is expected to facilitate increased awareness and adoption of Nyxoah's products, ultimately contributing to the company's goals of enhancing the standard of care for individuals with obstructive sleep apnea and related breathing disorders.

Nyxoah, Partnership, AAO-HNSF